BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 29270777)

  • 1. Association Between Polymorphisms in the Promoter Region of microRNA-34b/c and the Chemoradiotherapy Efficacy for Locally Advanced Esophageal Squamous Cell Carcinoma in Chinese Han Population.
    Bulibu J; Wang W; Tang Y; Li N; Saifuding K
    Pathol Oncol Res; 2019 Jan; 25(1):421-427. PubMed ID: 29270777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pri-miR-124 rs531564 and pri-miR-34b/c rs4938723 polymorphisms are associated with decreased risk of esophageal squamous cell carcinoma in Chinese populations.
    Zhang J; Huang X; Xiao J; Yang Y; Zhou Y; Wang X; Liu Q; Yang J; Wang M; Qiu L; Zheng Y; Zhang P; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M
    PLoS One; 2014; 9(6):e100055. PubMed ID: 24945256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China.
    Zhu J; Yang L; You W; Cui X; Chen Y; Hu J; Liu W; Li S; Song X; Wei Y; Zhang W; Li F
    Int J Clin Exp Pathol; 2015; 8(6):7332-40. PubMed ID: 26261633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population.
    Yin J; Wang X; Zheng L; Shi Y; Wang L; Shao A; Tang W; Ding G; Liu C; Liu R; Chen S; Gu H
    PLoS One; 2013; 8(11):e80570. PubMed ID: 24260422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
    Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
    Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between XIAP gene polymorphisms and esophageal squamous cell carcinoma susceptibility and prognosis in a Chinese population.
    Peng H; Wang LG; Wang XZ; Liu AJ
    Pathol Res Pract; 2017 Dec; 213(12):1482-1488. PubMed ID: 29037837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
    Wang WT; Guo CQ; Cui GH; Zhao S
    World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-449b rs10061133 and miR-4293 rs12220909 polymorphisms are associated with decreased esophageal squamous cell carcinoma in a Chinese population.
    Zhang P; Wang J; Lu T; Wang X; Zheng Y; Guo S; Yang Y; Wang M; Kolluri VK; Qiu L; Shen F; Fan L; Li J; Wang Y; Wei Q; Jin L; Wang J; Wang M
    Tumour Biol; 2015 Nov; 36(11):8789-95. PubMed ID: 26055141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter polymorphisms of miR-34b/c are associated with risk of gastric cancer in a Chinese population.
    Yang C; Ma X; Liu D; Wang Y; Tang R; Zhu Y; Xu Z; Yang L
    Tumour Biol; 2014 Dec; 35(12):12545-54. PubMed ID: 25190020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-1322 regulates ECRG2 allele specifically and acts as a potential biomarker in patients with esophageal squamous cell carcinoma.
    Zhang T; Zhao D; Wang Q; Yu X; Cui Y; Guo L; Lu SH
    Mol Carcinog; 2013 Aug; 52(8):581-90. PubMed ID: 22315007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Genetic Variant in miR-124 Decreased the Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Kazakh Population.
    Wu F; Li M; You W; Ji Y; Cui X; Hu J; Chen Y; Pang L; Li S; Wei Y; Yang L; Li F
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):29-34. PubMed ID: 29227754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of circulating microRNA-20a and let-7a in esophageal squamous cell carcinoma.
    He FC; Meng WW; Qu YH; Zhou MX; He J; Lv P; Ming L
    World J Gastroenterol; 2015 Apr; 21(15):4660-5. PubMed ID: 25914476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
    Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
    Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with renal cell cancer risk in a Chinese population.
    Zhang S; Qian J; Cao Q; Li P; Wang M; Wang J; Ju X; Meng X; Lu Q; Shao P; Zhang Z; Qin C; Yin C
    Mutagenesis; 2014 Mar; 29(2):149-54. PubMed ID: 24503183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single nucleotide polymorphism rs13042395 in the SLC52A3 gene as a biomarker for regional lymph node metastasis and relapse-free survival of esophageal squamous cell carcinoma patients.
    Tan HZ; Wu ZY; Wu JY; Long L; Jiao JW; Peng YH; Xu YW; Li SS; Wang W; Zhang JJ; Li EM; Xu LY
    BMC Cancer; 2016 Jul; 16():560. PubMed ID: 27472962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma.
    Li L; Wu J; Sima X; Bai P; Deng W; Deng X; Zhang L; Gao L
    Tumour Biol; 2013 Jun; 34(3):1919-23. PubMed ID: 23504554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pri-miR-34b/c rs4938723 Polymorphism Contributes to Coronary Artery Disease Susceptibility.
    Cen J; Xiong Q; Yang X; Guo J; Xiong XD; Zhang A
    Arch Med Res; 2019 May; 50(4):170-174. PubMed ID: 31499476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma.
    Xu Y; Liu L; Liu J; Zhang Y; Zhu J; Chen J; Liu S; Liu Z; Shi H; Shen H; Hu Z
    Int J Cancer; 2011 Jan; 128(2):412-7. PubMed ID: 20309940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.